Anti-BCL7A antibodies are used in the immunodetection of the protein BAF chromatin remodeling complex subunit BCL7A. In humans, the canonical protein has a reported length of 210 amino acid residues and a mass of 22.8 kDa. Up to 2 different isoforms have been reported for this protein. It is notably widely expressed in many tissue types. A member of the BCL7 protein family, BCL7A is known to be involved with chromatin remodeling and the regulation of cell differentiation. The BCL7A marker can be used to identify Transitional B Cells.* Synonyms for this target antigen include SMARCJ1, B-cell CLL/lymphoma 7 protein family member A, B-cell CLL/lymphoma 7A, B-cell CLL/lymphoma-7, BCL tumor suppressor 7A, and BCL7. BCL7A gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species.
*HuBMAP Human Reference Atlas v1.4